Skin Diseases, Infectious
Welcome,         Profile    Billing    Logout  
 74 Companies   57 Products   57 Products   41 Mechanisms of Action   2 Trials   680 News 


12345678910111213...1314»
  • ||||||||||  Trial completion, Enrollment change:  Analysis of Lyme Disease Lesions (clinicaltrials.gov) -  Dec 3, 2018   
    P=N/A,  N=27, Completed, 
    Active, not recruiting --> Completed | N=132 --> 59 Recruiting --> Completed | N=60 --> 27
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess (clinicaltrials.gov) -  Aug 30, 2018   
    P1/2,  N=6, Completed, 
    Terminated --> Completed Not yet recruiting --> Completed | N=100 --> 6 | Trial completion date: Apr 2019 --> Aug 2017 | Trial primary completion date: Oct 2018 --> Aug 2017
  • ||||||||||  Phase classification:  Analysis of Lyme Disease Lesions (clinicaltrials.gov) -  Mar 30, 2018   
    P,  N=60, Recruiting, 
    Recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2017 Phase classification: P=N/A --> P
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Registry for the Atopic Dermatitis Research Network (clinicaltrials.gov) -  Mar 2, 2018   
    P=N/A,  N=3386, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=2600 --> 3386 | Trial primary completion date: Feb 2020 --> Feb 2018 | Trial completion date: Feb 2020 --> Feb 2018
  • ||||||||||  mupirocin / Generic mfg.
    Trial completion, Trial completion date:  HOME2DS: Individualized vs. Household MRSA Decolonization (clinicaltrials.gov) -  Feb 28, 2018   
    P=N/A,  N=671, Completed, 
    Recruiting --> Completed | N=2600 --> 3386 | Trial primary completion date: Feb 2020 --> Feb 2018 | Trial completion date: Feb 2020 --> Feb 2018 Enrolling by invitation --> Completed | Trial completion date: Dec 2017 --> Nov 2017
  • ||||||||||  Trial initiation date, Trial primary completion date:  Improving Blood Safety and HIV Testing in Brazil (clinicaltrials.gov) -  Jan 18, 2018   
    P=N/A,  N=11900, Completed, 
    Phase classification: P1/2 --> P2 Initiation date: Mar 2012 --> Aug 2012 | Trial primary completion date: Sep 2013 --> May 2013
  • ||||||||||  Mycamine (micafungin) / Astellas
    Trial primary completion date:  Study of FK463 for the Treatment of Invasive Aspergillosis (clinicaltrials.gov) -  Jan 10, 2018   
    P2,  N=326, Completed, 
    Initiation date: Mar 2012 --> Aug 2012 | Trial primary completion date: Sep 2013 --> May 2013 Trial primary completion date: Dec 2002 --> Jan 2002
  • ||||||||||  Trial completion:  Protocol TARC-ABPA (clinicaltrials.gov) -  Nov 14, 2017   
    P=N/A,  N=29, Completed, 
    Trial primary completion date: Dec 2002 --> Jan 2002 Active, not recruiting --> Completed
  • ||||||||||  flucloxacillin sodium / Generic mfg.
    Enrollment change, Trial termination:  DANCE: Duration of ANtibiotic Therapy for CEllulitis (clinicaltrials.gov) -  Oct 9, 2017   
    P4,  N=151, Terminated, 
    N=60 --> 27 | Recruiting --> Terminated; Sponsor chose to close N=316 --> 151 | Active, not recruiting --> Terminated; Budget exceeded
  • ||||||||||  flucloxacillin sodium / Generic mfg.
    Enrollment closed, Trial primary completion date:  DANCE: Duration of ANtibiotic Therapy for CEllulitis (clinicaltrials.gov) -  Aug 16, 2017   
    P4,  N=316, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Mar 2017 --> Jul 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2018 --> Jul 2017
  • ||||||||||  albendazole / Generic mfg.
    Enrollment closed, Trial primary completion date:  Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana (clinicaltrials.gov) -  Jul 27, 2017   
    P3,  N=375, Active, not recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Oct 2018
  • ||||||||||  prednisone / Generic mfg.
    Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date:  The Use of Oral Steroids in the Treatment of Cellulitis (clinicaltrials.gov) -  Jul 25, 2017   
    P2,  N=0, Withdrawn, 
    Not yet recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Oct 2018 N=35 --> 0 | Initiation date: Sep 2009 --> Jan 2010 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2010 --> Aug 2010
  • ||||||||||  tigecycline / Generic mfg.
    Trial completion:  TIGER: Tygacil Drug Use Investigation (clinicaltrials.gov) -  Jul 17, 2017   
    P=N/A,  N=100, Completed, 
    N=35 --> 0 | Initiation date: Sep 2009 --> Jan 2010 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2010 --> Aug 2010 Active, not recruiting --> Completed
  • ||||||||||  Trial completion:  Structure of the Herpes Simplex Virus Receptor (clinicaltrials.gov) -  Jun 30, 2017   
    P=N/A,  N=60, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  griseofulvin / Generic mfg., terbinafine HCL / Generic mfg.
    Trial completion:  Terbinafine Compared to Griseofulvin in Children With Tinea Capitis (clinicaltrials.gov) -  May 30, 2017   
    P3,  N=720, Completed, 
    Trial primary completion date: Mar 2017 --> Aug 2017 Recruiting --> Completed
  • ||||||||||  Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
    Trial withdrawal:  Topical Infliximab in Autoimmune Eyes With Keratoprosthesis (clinicaltrials.gov) -  Apr 7, 2017   
    P1/2,  N=0, Withdrawn, 
    Trial primary completion date: Oct 2016 --> Aug 2017 Enrolling by invitation --> Withdrawn
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD)
    Enrollment change, Trial termination, Trial primary completion date:  Use of Corticosteroids in Children With Cellulitis (clinicaltrials.gov) -  Mar 13, 2017   
    P=N/A,  N=19, Terminated, 
    Active, not recruiting --> Completed N=124 --> 19 | Recruiting --> Terminated | Trial primary completion date: Oct 2016 --> Mar 2016; Calculated sample size not achieved
  • ||||||||||  tigecycline / Generic mfg.
    Trial primary completion date:  TIGER: Tygacil Drug Use Investigation (clinicaltrials.gov) -  Mar 1, 2017   
    P=N/A,  N=100, Active, not recruiting, 
    N=124 --> 19 | Recruiting --> Terminated | Trial primary completion date: Oct 2016 --> Mar 2016; Calculated sample size not achieved Trial primary completion date: Feb 2017 --> May 2017
  • ||||||||||  pentoxifylline / Generic mfg.
    Trial completion, Trial initiation date, Trial primary completion date:  Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis (clinicaltrials.gov) -  Jan 26, 2017   
    P2/3,  N=164, Completed, 
    Recruiting --> Completed | N=12 --> 15 | Trial primary completion date: Dec 2017 --> Jan 2017 Active, not recruiting --> Completed | Initiation date: Jan 2011 --> Mar 2012 | Trial primary completion date: Jan 2014 --> Jan 2015
  • ||||||||||  gentamicin sulfate / Generic mfg.
    Trial completion, Enrollment change, Trial initiation date, Trial primary completion date:  PAGELEC: WR 279,396 for the Treatment of Cutaneous Leishmaniasis (clinicaltrials.gov) -  Jan 26, 2017   
    P2,  N=18, Completed, 
    Active, not recruiting --> Completed | Initiation date: Jan 2011 --> Mar 2012 | Trial primary completion date: Jan 2014 --> Jan 2015 Active, not recruiting --> Completed | N=30 --> 18 | Initiation date: Jun 2014 --> Sep 2013 | Trial primary completion date: Sep 2017 --> Dec 2015
  • ||||||||||  flucloxacillin sodium / Generic mfg.
    Trial primary completion date:  DANCE: Duration of ANtibiotic Therapy for CEllulitis (clinicaltrials.gov) -  Jan 24, 2017   
    P4,  N=316, Recruiting, 
    Recruiting --> Completed Trial primary completion date: Apr 2017 --> Jan 2018
  • ||||||||||  tigecycline / Generic mfg.
    Trial primary completion date:  TIGER: Tygacil Drug Use Investigation (clinicaltrials.gov) -  Nov 4, 2016   
    P=N/A,  N=100, Active, not recruiting, 
    Recruiting --> Completed | Trial primary completion date: Jun 2017 --> Oct 2016 Trial primary completion date: Jun 2017 --> Jan 2017